Fresenius Helios acquires Spanish fertility services provider Eugin Group for €430M

Germany´s Fresenius Helios, owner of Quirónsalud, has acquired Eugin´s group of assisted reproduction clinics from NMC Health for €430m.

Posté le Wednesday, December 23rd 2020
Fresenius Helios acquires Spanish fertility services provider Eugin Group for €430M

Fresenius CEO, Stephan Sturm

According to a statement, the transaction will be financed with cash and existing lines of credit and is expected to close in the first half of 2021.

Specifically, it has acquired 100% of the share capital of Luarmia SL Spain, which holds the global operations of the Eugin Group except in the United States. For that market, it has purchased 100% of NMC Eugin US Corporation, which owns 70% of the shares of Boston IVF; the rest is in the hands of its doctors.

In 2019, Eugin Group generated sales of €160m and obtained a gross operating profit (ebitda) of €31m.

Eugin Group will start a new business of Fresenius Helios and will report together with Helios Germany and Helios Spain. Eugin´s network comprises 31 clinics and 34 additional sites in nine countries on three continents, with around 1,300 employees. The United States, Spain, Brazil, Italy and Sweden are the largest markets for Eugin Group, which also operates clinics in Denmark, Argentina, Colombia and Latvia.

A team from Freshfields Bruckhaus Deringer has advised Helios Health (holding of the Fresenius-Helios private hospital and clinics business segment), which included Spanish partners Javier Monzón and Bosco Montejo, and US partners John Fisher and Paul Humphreys.